Immunobiology of vasoactive intestinal peptide (VIP)
- 1 January 2000
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 21 (1) , 7-11
- https://doi.org/10.1016/s0167-5699(99)01525-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T cellsJournal of Neuroimmunology, 1999
- Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-JunJournal of Biological Chemistry, 1998
- Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophagesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1997
- Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Vasoactive Intestinal Peptide (VIP) Stimulate Interleukin-6 Production through the Third Subtype of PACAP/VIP Receptor in Rat Bone Marrow-Derived Stromal CellsEndocrinology, 1997
- Chronic inflammation caused by lymphotoxin is lymphoid neogenesis.The Journal of Experimental Medicine, 1996
- The syntax of immune-neuroendocrine communicationImmunology Today, 1994
- Gene Expression of VIP Receptor in Rat LymphocytesBiochemical and Biophysical Research Communications, 1994
- Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptideNeuron, 1992
- Demonstration of immunoreactive vasoactive intestinal peptide (IR-VIP) and somatostatin (IR-SOM) in rat thymusBrain, Behavior, and Immunity, 1990
- Release of vasoactive intestinal polypeptide in mast cells by histamine liberatorsNature, 1978